Temazepam is a classic sleep benzodiazepine: effective for the same reason it can become a problem.

Diazepam is a classic benzodiazepine with a long half-life, fast familiarity, and risks that shouldn't be waved away.

Nefazodone is split between a useful antidepressant profile and a liver-risk history that keeps it a selective tool.

Isocarboxazid is an old MAOI that can work extremely well and still makes clinicians cautious because the rules matter.

The selegiline patch is a genuinely unusual antidepressant option: MAOI biology with a delivery system that changes the risk math.

Tranylcypromine is a serious MAOI for treatment-resistant depression. It can work when cleaner drugs fail, but the diet and interaction rules matter.

Acamprosate (Campral) helps you stay sober after detox, not get you there. Non-addictive, renally cleared, six pills a day. Who it fits and who it doesn't.

Phenelzine is an old MAOI that can still beat newer options for atypical or resistant depression, if the food and medication rules are realistic.

Desipramine is an older norepinephrine-leaning tricyclic. It can still work, but it asks for more side-effect and safety respect.

Clomipramine is an older TCA for OCD that can hit hard when SSRIs fall short, but side effects, safety rules, and follow-up matter.

Minoxidil (Rogaine): what it does, who it works for, topical foam versus low-dose oral minoxidil, the dread shed, and the side effects worth knowing.

Imipramine is an old tricyclic that can help depression and panic, but the burden is harder to justify when cleaner options fit.